Samsung Event: Everything Announced Disney Plus Price Hike NFL Preseason Schedule Deals on Galaxy Z Fold 4 Best 65-Inch TV Origin PC Evo17-S Review Best Buy Anniversary Sale Monkeypox Myths
Want CNET to notify you of price drops and the latest stories?
No, thank you

Neoforma may restate revenue

Neoforma, which operates online marketplaces for hospitals, said Tuesday that it might restate financial results after a review of accounting related to stock it issued to business partners in 2000. If the company were to revise results, under a different interpretation of rules governing the amortization of those stocks, it would have posted lower revenue, lower net losses and higher earnings per share for the past two years, Neoforma said. Questions about the treatment of the transactions were raised by the company's new auditor, Deloitte & Touche, which replaced previous auditor Arthur Anderson.

Neoforma said it's seeking consultation on the matter from the Securities and Exchange Commission and that any revisions would not affect its cash flow. The company said the problem is a result of complex rules and is nothing like recent accounting scandals at Enron and WorldCom that have hammered the business world. "The matters do not reflect wrongdoing on anyone's part," Neoforma stated in a letter to stockholders.